ProtoKinetix, Inc. (PKTX) Executive Compensation
ProtoKinetix, Inc. (PKTX) is a publicly traded company, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PKTX
CIK: 1128189
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Davidson & Company LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerCarmen Newnham
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-K | 2026-09-03 | 2025-12-31 | ANNUAL REPORT | 0001079973-26-001218 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q Filing | 0001079973-26-001119 | View SEC Doc Filr Page |
| 3 | 2026-07-28 | 2026-06-17 | 3 Filing | 0001079973-26-000979 | View SEC Doc Filr Page |
| 3 | 2026-07-07 | 2026-06-17 | 3 Filing | 0001079973-26-000930 | View SEC Doc Filr Page |
| 3 | 2026-06-24 | 2026-06-17 | 3 Filing | 0001079973-26-000869 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-03-31 | FORM 8-K | 0001079973-26-000855 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q Filing | 0001079973-26-000677 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K Filing | 0001079973-26-000402 | View SEC Doc Filr Page |
| D/A | 2025-12-23 | — | D/A Filing | 0001128189-25-000008 | View SEC Doc Filr Page |
| 8-K | 2025-11-21 | 2025-11-21 | FORM 8-K | 0001553350-25-000111 | View SEC Doc Filr Page |
| 8-K/A | 2025-11-19 | 2025-11-13 | FORM 8-K | 0001079973-25-001802 | View SEC Doc Filr Page |
| 8-K | 2025-11-17 | 2025-11-13 | FORM 8-K | 0001079973-25-001778 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | FORM 10-Q | 0001079973-25-001708 | View SEC Doc Filr Page |
| 8-K | 2025-10-10 | 2025-10-06 | FORM 8-K | 0001079973-25-001594 | View SEC Doc Filr Page |
| D | 2025-10-02 | — | D Filing | 0001128189-25-000007 | View SEC Doc Filr Page |
| DEF 14A | 2025-09-15 | 2025-10-05 | DEFINITIVE PROXY STATEMENT | 0001079973-25-001456 | View SEC Doc Filr Page |
| PRE 14A | 2025-09-05 | 2025-09-05 | PRELIMINARY PROXY STATEMENT | 0001079973-25-001430 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | FORM 10-Q | 0001079973-25-001254 | View SEC Doc Filr Page |
| D/A | 2025-08-12 | — | D/A Filing | 0001128189-25-000004 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | FORM 10-Q | 0001079973-25-000816 | View SEC Doc Filr Page |
| D/A | 2025-05-14 | — | D/A Filing | 0001128189-25-000003 | View SEC Doc Filr Page |
| 10-K | 2025-03-28 | 2024-12-31 | ANNUAL REPORT | 0001079973-25-000516 | View SEC Doc Filr Page |
| D | 2025-03-27 | — | D Filing | 0001128189-25-000002 | View SEC Doc Filr Page |
| D/A | 2025-01-21 | — | D/A Filing | 0001128189-25-000001 | View SEC Doc Filr Page |
| D/A | 2024-11-25 | — | D/A Filing | 0001128189-24-000005 | View SEC Doc Filr Page |